Compare Liquidia Corporation Common Stock (LQDA) vs Nasdaq Inc (NDAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Nasdaq Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.5 (market cap $2.40B), while Nasdaq Inc trades at $92.08 (market cap $52.25B). The key difference: Nasdaq Inc is far larger — about 21.8× Liquidia Corporation Common Stock's market cap, and Nasdaq Inc pays a 1.24% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nasdaq Inc for 126 Days on average.
| LQDA | NDAQ | |
|---|---|---|
Market Cap | $2.40B | $52.25B |
Volume | 2,857,547 | 2,420,834 |
Sector | Health | Financials |
52-Week High | $91.03 | $100.98 |
52-Week Low | $22.02 | $76.85 |
Typical Hold Time | 0 Days | 126 Days |
Enterprise Value | $2.30B | $58.71B |
Dividend Yield | — | 1.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nasdaq (NDAQ) trades at $91.96, down 2.47% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamentals with 2025 revenue of $8.26B and net income of $1.79B, achieving a 21.64% profit margin. Recent earnings beats and analyst consensus of $110.43 price target reflect confidence in growth driven by financial technology and AI initiatives.
NDAQ presents a compelling investment case with solid profitability and strategic positioning in market infrastructure. Key risks include market volatility sensitivity and debt levels, but strong cash flow and institutional support provide stability. The stock offers upside potential aligned with analyst targets, supported by recurring revenue growth and technology adoption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →
